The ownership structure of Grace Therapeutics (GRCE) stock is a mix of institutional, retail, and individual investors. , and 88.32% is owned by Public Companies and Individual Investors.
The ownership structure of Grace Therapeutics (GRCE) stock is a mix of institutional, retail, and individual investors. Approximately 90.54% of the company’s stock is owned by Institutional Investors, 9.46% is owned by Insiders
What percentage of Grace Therapeutics, Inc. (GRCE) stock is held by institutional investors?
According to the latest TipRanks data, approximately 9.46% of Grace Therapeutics, Inc. (GRCE) stock is held by institutional investors.
What percentage of Grace Therapeutics, Inc. (GRCE) stock is held by retail investors?
According to the latest TipRanks data, approximately 88.32% of Grace Therapeutics, Inc. (GRCE) stock is held by retail investors.
Who owns the most shares of Grace Therapeutics, Inc. (GRCE)?
Vanguard owns the most shares of Grace Therapeutics, Inc. (GRCE).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.